Statistical analyses Data were typically expressed as the mean of at least three biological replicates standard error of the mean (SEM)
Research Evidence: Studies, including a randomized controlled trial published in Clinical, Cosmetic and Investigational Dermatology, have shown that oral glutathione (500 mg daily) taken over 8-12 weeks can result in noticeable improvement in melasma severity compared to placebo
As reported by the American Journal of Managed Care, the approval of an oral semaglutide formulation marked the beginning of what many are calling the oral GLP-1 era. In December 2025, the FDA approved the Wegovy (semaglutide) tablet as the first once-daily oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight
Understanding whether peptides expire helps set appropriate expectations for shelf life across all peptide products
Welcome to Hospitalogy, a newsletter breaking down healthcare finance, M&A, and strategy twice weekly